Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia
T Damci, S Tatliagac, Z Osar, H Ilkova - European Journal of Internal …, 2003 - Elsevier
Background: Hertriglyceridemia is commonly encountered in type 2 diabetic patients.
Fibrates are a group of drugs that efficiently decrease triglycerides, increase HDL, and
improve the prognosis in both diabetic and nondiabetic patients. However, the effects of
fibrates on glycemic control, blood pressure, fasting serum insulin, and leptin concentrations
are not clear. The present study addresses the question of whether fenofibrate treatment in
hypertriglyceridemic type 2 diabetic patients leads to changes in metabolic control, body …
Fibrates are a group of drugs that efficiently decrease triglycerides, increase HDL, and
improve the prognosis in both diabetic and nondiabetic patients. However, the effects of
fibrates on glycemic control, blood pressure, fasting serum insulin, and leptin concentrations
are not clear. The present study addresses the question of whether fenofibrate treatment in
hypertriglyceridemic type 2 diabetic patients leads to changes in metabolic control, body …